These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 25547827)
1. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas. Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827 [TBL] [Abstract][Full Text] [Related]
2. Differential biomarker expression in head and neck cancer correlates with anatomical localization. Tamás L; Szentkúti G; Eros M; Dános K; Brauswetter D; Szende B; Zsákovics I; Krenács T Pathol Oncol Res; 2011 Sep; 17(3):721-7. PubMed ID: 21487776 [TBL] [Abstract][Full Text] [Related]
3. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation. Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684 [TBL] [Abstract][Full Text] [Related]
4. p16, p53 and EGFR expression in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters. Gupta S; Pandey P; Verma S; Verma A J Cancer Res Ther; 2024 Apr; 20(3):881-887. PubMed ID: 39023595 [TBL] [Abstract][Full Text] [Related]
5. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck. Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415 [TBL] [Abstract][Full Text] [Related]
6. Aberrant Kif2a and Ki67 expression predicts poor survival in laryngeal squamous cell carcinoma. Zhang Q; Zhang W; Zhang J; Xu H; You Y Auris Nasus Larynx; 2016 Aug; 43(4):433-9. PubMed ID: 26602436 [TBL] [Abstract][Full Text] [Related]
7. [Association of the expression of p53 and p16INK4A with the clinical and morphological characteristicsof patients with head and neck squamous cell cancer]. Stukan AI; Chukhray OY; Porkhanov VA; Bodnya VN Arkh Patol; 2019; 81(3):12-18. PubMed ID: 31317926 [TBL] [Abstract][Full Text] [Related]
8. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma. Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228 [TBL] [Abstract][Full Text] [Related]
9. BP180 Is a Prognostic Factor in Head and Neck Squamous Cell Carcinoma. Meng X; Matsumoto F; Mori T; Miura N; Ino Y; Onidani K; Kobayashi K; Matsuzaki Y; Yoshimoto S; Ikeda K; Honda K Anticancer Res; 2021 Feb; 41(2):1089-1099. PubMed ID: 33517320 [TBL] [Abstract][Full Text] [Related]
10. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer. Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. Yuen PW; Man M; Lam KY; Kwong YL J Clin Pathol; 2002 Jan; 55(1):58-60. PubMed ID: 11825926 [TBL] [Abstract][Full Text] [Related]
12. The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study. Solomon MC; Vidyasagar MS; Fernandes D; Guddattu V; Mathew M; Shergill AK; Carnelio S; Chandrashekar C Med Oncol; 2016 Dec; 33(12):138. PubMed ID: 27817107 [TBL] [Abstract][Full Text] [Related]
13. Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma. Barber BR; Biron VL; Klimowicz AC; Puttagunta L; Côté DW; Seikaly H J Otolaryngol Head Neck Surg; 2013 Oct; 42(1):53. PubMed ID: 24401183 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck. Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154 [TBL] [Abstract][Full Text] [Related]
15. P53, p16 and Ki67 immunoexpression in cutaneous squamous cell carcinoma and its precursor lesions. Marinescu A; Stepan AE; Mărgăritescu C; Marinescu AM; Zăvoi RE; Simionescu CE; Niculescu M Rom J Morphol Embryol; 2016; 57(2 Suppl):691-696. PubMed ID: 27833960 [TBL] [Abstract][Full Text] [Related]
16. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma. Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475 [TBL] [Abstract][Full Text] [Related]
17. Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma. Morita S; Nakamaru Y; Homma A; Yasukawa S; Hatakeyama H; Sakashita T; Kano S; Fukuda A; Fukuda S Int J Clin Oncol; 2017 Feb; 22(1):181-189. PubMed ID: 27488595 [TBL] [Abstract][Full Text] [Related]
18. Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Rittà M; De Andrea M; Mondini M; Mazibrada J; Giordano C; Pecorari G; Garzaro M; Landolfo V; Schena M; Chiusa L; Landolfo S Head Neck; 2009 Mar; 31(3):318-27. PubMed ID: 19072995 [TBL] [Abstract][Full Text] [Related]
19. The role of protein p16(INK4a) in glottic laryngeal squamous cell carcinoma. Kalfert D; Celakovsky P; Laco J; Ludvikova M Pathol Oncol Res; 2014 Oct; 20(4):909-15. PubMed ID: 24760498 [TBL] [Abstract][Full Text] [Related]
20. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas. García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]